|Articles|February 1, 2009
What are your trilostane dosing and monitoring recommendations in dogs with hyperadrenocorticism? Should I switch treatment from mitotane to trilostane in dogs being treated for hyperadrenocorticism? (4:47)
Author(s)David S. Bruyette, DVM, DACVIM
Dr. David Bruyette discusses how to administer and monitor trilostane in dogs with hyperadrenocorticism, including whether to switch affected patients from mitotane to trilostane.
Advertisement
video
Advertisement
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on dvm360
1
Generic drug for canine osteoarthritis receives FDA approval
2
Preventing periodontal disease in dogs
3
Minimally invasive sterilization for canines and felines
4
FDA conditionally approves combination parasiticide for New World screwworm
5